Q4 Earnings Estimate for INSP Issued By Leerink Partnrs

Inspire Medical Systems, Inc. (NYSE:INSP) – Equities research analysts at Leerink Partnrs boosted their Q4 2024 earnings per share (EPS) estimates for Inspire Medical Systems in a research note issued on Monday, November 4th. Leerink Partnrs analyst M. Kratky now expects that the company will earn $0.77 per share for the quarter, up from their previous estimate of $0.72. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $0.75 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ Q4 2025 earnings at $1.12 EPS and FY2028 earnings at $5.77 EPS.

Several other research analysts also recently commented on INSP. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday. KeyCorp reduced their price target on Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating for the company in a research report on Wednesday, August 7th. Wells Fargo & Company boosted their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research note on Tuesday. Stifel Nicolaus restated a “hold” rating and issued a $200.00 target price (up previously from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday. Finally, Leerink Partners upped their price target on Inspire Medical Systems from $167.00 to $197.00 and gave the company a “market perform” rating in a research report on Tuesday, September 10th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $227.75.

Inspire Medical Systems Stock Up 6.3 %

Shares of NYSE:INSP opened at $211.63 on Wednesday. The firm has a market capitalization of $6.31 billion, a PE ratio of 197.79 and a beta of 1.36. The company has a 50-day moving average price of $201.94 and a two-hundred day moving average price of $179.94. Inspire Medical Systems has a twelve month low of $123.00 and a twelve month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.51% and a net margin of 4.37%. The firm had revenue of $203.20 million for the quarter, compared to analysts’ expectations of $197.59 million. During the same quarter in the prior year, the firm earned ($0.29) EPS. The business’s revenue for the quarter was up 32.6% compared to the same quarter last year.

Insider Transactions at Inspire Medical Systems

In related news, insider Randy Ban sold 4,861 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $188.55, for a total value of $916,541.55. Following the completion of the transaction, the insider now directly owns 3,056 shares in the company, valued at approximately $576,208.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Randy Ban sold 4,861 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $188.55, for a total transaction of $916,541.55. Following the transaction, the insider now directly owns 3,056 shares of the company’s stock, valued at approximately $576,208.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Shawn Mccormick sold 800 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the completion of the sale, the director now directly owns 23,140 shares of the company’s stock, valued at approximately $5,090,800. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,692 shares of company stock valued at $1,099,207 in the last quarter. Insiders own 4.10% of the company’s stock.

Hedge Funds Weigh In On Inspire Medical Systems

A number of large investors have recently added to or reduced their stakes in INSP. Mutual of America Capital Management LLC bought a new position in shares of Inspire Medical Systems during the third quarter valued at about $947,000. CIBC Asset Management Inc purchased a new stake in Inspire Medical Systems during the 3rd quarter valued at about $285,000. ING Groep NV bought a new position in Inspire Medical Systems during the 3rd quarter worth approximately $1,477,000. KBC Group NV increased its stake in Inspire Medical Systems by 16.9% in the 3rd quarter. KBC Group NV now owns 870 shares of the company’s stock worth $184,000 after purchasing an additional 126 shares during the period. Finally, Victory Capital Management Inc. lifted its position in Inspire Medical Systems by 0.8% in the third quarter. Victory Capital Management Inc. now owns 82,849 shares of the company’s stock valued at $17,485,000 after purchasing an additional 643 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.